Tuberculosis (TB): Practice Essentials, Background, Pathophysiology
Impact Of Helicobacter Pylori Status On GERD, Barrett's Esophagus And Esophageal Cancer
Helicobacter pylori (H. Pylori) is a ubiquitous human pathogen that infects up to 50% of the world's population. Its involvement in the etiology of various gastrointestinal disorders, including gastritis, peptic ulcer disease, and gastric cancer, is well established. In recent years, the relationship between H. Pylori infection and gastroesophageal reflux disease (GERD) has garnered significant attention. This review article aims to summarize the current understanding of the impact of H. Pylori infection and its eradication on GERD and its related complications, including Barrett's esophagus (BE) and esophageal adenocarcinoma (EAC).
Gastric Acid Secretion and H. Pylori Infection
Gastric acid secretion plays a crucial role in acid reflux disease, which can be modulated by H. Pylori infection. Studies have shown that H. Pylori infection can increase or decrease gastric acid secretion depending on its distribution within the stomach. For instance, antrum-predominant infection has been shown to augment acid secretion by stimulating parietal cells and gastrin induction, ultimately contributing to GERD development. Conversely, corpus-predominant infection can decrease acid secretion, potentially offering protection against GERD.
H. Pylori and GERD
While the direct causal link between H. Pylori infection and GERD remains controversial, several studies have reported an association between the two conditions. The presence of H. Pylori may influence GERD symptoms by altering the composition of the upper gastrointestinal microbiota, modulating gastric acid secretion, and influencing esophageal motility.
Several meta-analyses have evaluated the effect of H. Pylori eradication on GERD symptoms. While some studies have reported an increase in GERD symptoms after eradication, others have shown no significant change or even improvement. These inconsistent results highlight the need for further research to clarify the exact role of H. Pylori in GERD pathogenesis.
H. Pylori and Barrett's Esophagus (BE)
Barrett's esophagus is a premalignant condition that can progress to esophageal adenocarcinoma. Early studies investigating the relationship between H. Pylori infection and BE yielded inconclusive results. However, recent meta-analyses have consistently reported a protective effect of H. Pylori against BE development. This protective effect is likely mediated through several mechanisms, including downregulation of tumor-promoting inflammatory responses and maintenance of oral microbiota balance.
H. Pylori and Esophageal Adenocarcinoma (EAC)
The link between H. Pylori infection and esophageal adenocarcinoma is complex. While H. Pylori infection appears to confer protection against EAC, the mechanisms underlying this phenomenon are not fully understood. It has been suggested that CagA-positive H. Pylori strains may play a role in preventing EAC by downregulating inflammatory responses and maintaining oral microbiota balance. Additionally, H. Pylori-induced apoptosis of Barrett's-derived EAC cells has been reported, further supporting its potential protective role.
Clinical Implications and Future Directions
Understanding the relationship between H. Pylori infection and GERD-related complications has important clinical implications. The protective effect of H. Pylori against BE and EAC highlights the need for caution when considering eradication therapy in patients with these conditions. Further research is needed to elucidate the underlying mechanisms of H. Pylori's protective effects and to identify biomarkers that can guide personalized treatment strategies.
Conclusions
In summary, the relationship between H. Pylori infection and GERD-related complications is complex and multifaceted. While H. Pylori infection appears to offer protection against BE and EAC, its role in GERD symptomology remains uncertain. Further research is necessary to better understand the pathogenesis of these conditions and to develop effective prevention and treatment strategies.
Full text
https://www.Xiahepublishing.Com/2994-8754/JTG-2023-00020
The study was recently published in the Journal of Translational Gastroenterology.
Journal of Translational Gastroenterology (JTG) dedicates to improving clinical diagnosis and treatment, advancing understanding of the molecular mechanisms, and promoting translation from bench to bedside of gastrointestinal, hepatobiliary, and pancreatic diseases. The aim of JTG is to provide a forum for the exchange of ideas and concepts on basic, translational, and clinical aspects of gastroenterology, and promote cross-disciplinary research and collaboration.
Follow us on X: @xiahepublishing
Follow us on LinkedIn: Xia & He Publishing Inc.
Disclaimer: AAAS and EurekAlert! Are not responsible for the accuracy of news releases posted to EurekAlert! By contributing institutions or for the use of any information through the EurekAlert system.
All About Voquezna
Below is important information you should consider before taking Voquezna.
InteractionsTaking a drug with certain medications, vaccines, foods, and other things can affect how the drug works. These effects are called interactions.
Voquezna can interact with several other medications. It can also interact with certain supplements as well as certain lab tests.
Before taking Voquezna, talk with your doctor and pharmacist. Tell them about all prescription, over-the-counter, and other drugs you take. Also tell them about any vitamins, herbs, and supplements you use. Sharing this information can help you avoid potential interactions.
Drug interactionsBelow is a list of medications that can interact with Voquezna. This list does not contain all drugs that may interact with Voquezna. If you have questions about drug interactions that may affect you, ask your doctor or pharmacist.
* This enzyme (protein) is in the liver and helps break down certain drugs, including Voquezna.
Voquezna and alcoholAlcohol is not known to interact with Voquezna. But alcohol may worsen certain side effects from taking Voquezna, including nausea and headache. In addition, alcohol may worsen symptoms of esophagitis or gastroesophageal reflux disease (GERD), such as heartburn. Because of this, your doctor may recommend that you avoid alcohol or limit the amount you consume.
If you have questions about consuming alcohol with your condition or treatment plan, talk with your doctor or pharmacist.
Other interactionsVoquezna can interact with other substances such as:
It's not known whether it's safe to take Voquezna during pregnancy.
Voquezna's manufacturer is gathering information about the drug's use during pregnancy. If you become pregnant while taking Voquezna, you or your doctor can report the pregnancy to Phathom Pharmaceuticals by calling 888-775-7428. Talk with your doctor to learn more.
It's not known whether Voquezna passes into breast milk or what effects (if any) it could have on a child who is breastfed. But because of the possible risks, breastfeeding while taking Voquezna is not recommended.
If you're pregnant or breastfeeding, or planning to become pregnant or to breastfeed, talk with your doctor before starting Voquezna treatment.
WarningsVoquezna can sometimes cause harmful effects in people who have certain conditions. This is known as a drug-condition interaction. Other factors may also affect whether Voquezna is a good treatment option for you.
Talk with your doctor about your health history before you take Voquezna. Be sure to tell them if any of the following factors apply to you:
Genital Herpes: When Is It Contagious? Is It Forever?
backQuestion:I just found out I have genital herpes. Does this mean I'll always have it? What should I tell my partner?
Answer:You're definitely contagious when you've got an outbreak, and probably for a few days before. Unfortunately, a few people are contagious between outbreaks, even if they don't have symptoms, and there isn't an easy way to find out who those folks are. However, normally speaking, if you don't have symptoms or lesions, you're probably not contagious.
It's important to get new sores in the genital area checked right away: it's easier to diagnose problems when they can be seen, and if your initial outbreak is treated early, you're less likely to get recurrences. Most folks who get herpes only get one outbreak, and those who get multiple outbreaks don't get many. Folks who get lots of outbreaks can suppress them with oral medications taken daily.
I know it's not much consolation, but herpes is a very common condition; the majority of American adults have it. And though the virus may always be in your body, chances are it won't be a major problem.
By Dr. Flash Gordon
Note: To print this document, click on this frame, then choose File --> Print Frame or Print.
Got a question? Ask a doctor at WebMD.
Copyright ©1999 Direct Medical Knowledge, Inc.
WebMD terms and conditions.
Comments
Post a Comment